The Rise of Carbapenem-Resistant Acinetobacter baumannii

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|2|223-238

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.2, 2013-01, pp. : 223-238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Doxycycline may be a suitable treatment against Acinetobacter baumannii

By  

Inpharma, Vol. 1, Iss. 1653, 2008-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Therapeutic options for Acinetobacter baumannii infections

By Vila Jordi   Pachn Jernimo  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 4, 2008-03 ,pp. : 587-599

Informa Healthcare

Access to resources Recommend Favorite

First Steps Towards a Vaccine against Acinetobacter baumannii

By  

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 10, 2013-11 ,pp. : 897-902

Bentham Science Publishers

Access to resources Recommend Favorite

Carbapenems/immunosuppressants: Sepsis resulting from carbapenem-resistant Enterobacter aerogenes during immunosuppressant therapy: case report

By  

Reactions Weekly, Vol. 1, Iss. 1278, 2009-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Corticosteroids/mycophenolate mofetil/tacrolimus: Fatal carbapenem-resistant Klebsiella infection: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1279, 2009-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite